Maha H. Hussain

Maha H. Hussain is the Genevieve E. Teuton Professor of Medicine and deputy director of the Lurie Comprehensive Cancer Center at Northwestern University's Feinberg School of Medicine. She is an oncologist focusing on genitourinary cancers.

Biography

Hussain was born and raised in Baghdad, Iraq. Both of her parents were chemists.[1]

Hussain studied medicine at the College of Medicine University of Baghdad, graduating in 1980. She did her residency in internal medicine from 1980 to 1983 and fellowship in hematology/oncology from 1983 to 1986 at Wayne State University School of Medicine in Detroit, Michigan.[2] After finishing her training, she worked as a hematologist/oncologist at the VA Medical Center in Detroit for ten years.[3]

She joined the faculty at the University of Michigan in 2002.[3] There, she was the Cis Maisel Professor of Oncology[4] and assistant director of clinical research.[5] In 2016,[5] she joined the faculty at Northwestern University, where she is the Genevieve E. Teuton Professor of Medicine and deputy director of the Robert H. Lurie Comprehensive Cancer Center at the Feinberg School of Medicine.[4][6] Hussain was a member (2004-2008) and chair (2007-2008) of the U.S. Food and Drug Administration Oncology Drug Advisory Committee.[7]

In 2010, she was elected as a fellow of the American Society for Clinical Oncology (ASCO). She has served on ASCO's board of directors and Clinical Practice Guidelines Committee.[8] In 2015, she was named one of the Giants of Cancer Care by OncLive.[4]

Research

Hussain's research centers on treatment protocols for prostate cancer, seeking to improve outcomes. Hussain conducted an analysis of two major clinical trials and determined that despite stable PSA levels, prostate cancer may have advanced as indicated by imaging scans.[9] Hussain's findings challenge the assumption that PSA numbers are sufficient to monitor prostate cancers and calls for more tracking of prostate cancers.[9] Hussain found that men with hormone resistant prostate cancer and harboring BRCA mutations had better outcomes when treated with a PARP inhibitor drug than men treated with traditional hormone therapy.[10]

Awards

Hussain received the University of Michigan Comprehensive Cancer Center Leadership Award in 2007 and the University of Michigan Medical School League of Research Excellence award in 2011.[11] In 2010, she was elected as a fellow of the American Society for Clinical Oncology (ASCO). She has served on ASCO's board of directors and Clinical Practice Guidelines Committee.[8] In 2015, she was named one of the Giants of Cancer Care by OncLive.[4] In 2024, ScholarGPS named Hussain a Top Scholar[12] and Top 1% of America's Most Honored Doctors 2024.[7]

In 2025, Hussain received the first Prostate Cancer Foundation Women in Science Lifetime Achievement Award.[13] The award recognizes her groundbreaking research in improving the treatment and management of patients with prostate cancer.

References

  1. ↑ Piana, Ronald. "Maha Hussain, MD, FACP, FASCO, Credits Collaboration for Her Contributions to Genitourinary Cancer - The ASCO Post". www.ascopost.com. Retrieved 9 May 2019.
  2. ↑ "Maha H.A. Hussain, MBChB : Physician Profile: Robert H. Lurie Comprehensive Cancer Center of Northwestern University : Feinberg School of Medicine: Northwestern University". www.cancer.northwestern.edu. Retrieved 9 May 2019.
  3. 1 2 Panjwani, Laura (6 August 2016). "Caring for US Veterans Helped Lead Iraqi Immigrant to Develop Prostate Cancer Advances". Vol. 17/No. 15. Retrieved 9 May 2019.
  4. 1 2 3 4 "Maha H. Hussain, MB ChB | Giants of Cancer Care". www.giantsofcancercare.com. Retrieved 9 May 2019.
  5. 1 2 "Deputy Director - Maha H. Hussain, MD: Robert H. Lurie Comprehensive Cancer Center of Northwestern University : Feinberg School of Medicine: Northwestern University". www.cancer.northwestern.edu. Retrieved 9 May 2019.
  6. ↑ "Hussain Joins Northwestern; Douillard Named ESMO CMO". The Cancer Letter. 2016-03-25. Retrieved 2026-08-27.
  7. 1 2 "Maha Hussain". Prostate Cancer UK. Retrieved 2026-08-27.
  8. 1 2 "Maha H. A. Hussain, MD, FACP, FASCO". ASCO. Retrieved 9 May 2019.
  9. 1 2 Dimmer, Olivia (2026-04-24). "Scans Can Reveal Hidden Prostate Cancer Progression". News Center. Retrieved 2026-08-27.
  10. ↑ hme0988 (2024-05-09). "Leading Prostate Cancer Research for More than 20 Years". News Center. Retrieved 2026-08-27.{{cite web}}: CS1 maint: numeric names: authors list (link)
  11. ↑ "Maha Hussain". Prostate Cancer UK. Retrieved 2026-08-27.
  12. ↑ "Scholar GPS". scholargps.com. Retrieved 2026-08-27.
  13. ↑ Gallagher, Kathryn (2025-10-24). "Prostate Cancer Foundation Honors Maha Hussain, MD, FACP, FASCO, Recipient of the First PCF Women in Science Lifetime Achievement Award". Prostate Cancer Foundation. Retrieved 2026-08-27.
This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.